IDEAL_ANSWER:
- Emapalumab is a human monoclonal antibody directed against interferon-γ (IFN-γ) that was approved by the Food and Drug Administration for primary hemophagocytic lymphohistiocytosis (HLH).

EXACT_ANSWER:
- primary hemophagocytic lymphohistiocytosis